Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/23375
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects
Author: Gamble, J.
Xia, P.
Hahn, C.
Drew, J.
Drogemuller, C.
Brown, D.
Vadas, M.
Citation: International Journal of Cancer, 2006; 118(10):2412-2420
Publisher: Wiley-liss
Issue Date: 2006
ISSN: 0020-7136
1097-0215
Statement of
Responsibility: 
Gamble, Jennifer R. ; Xia, Pu ; Hahn, Christopher N. ; Drew, Jenny J. ; Drogemuller, Christopher J. ; Brown, David ; Vadas, Mathew A.
Abstract: Phenoxodiol (2H-1-benzopyran-7-0,1, 3-[4-hydroxyphenyl], PXD) is a synthetic analogue of the naturally-occurring plant isoflavone and anticancer agent, genistein. PXD directly induces mitotic arrest and apoptosis in most cancer cells and is currently undergoing clinical trials, as a chemotherapeutic in ovarian and prostate cancers. We show here that PXD also exhibits potent antiangiogenic properties. Thus, it inhibited endothelial cell proliferation, migration and capillary tube formation and inhibited expression of the matrix metalloproteinase MMP-2, a major matrix degrading enzyme. Importantly, we demonstrate that PXD is functional in vivo since it inhibited the extent of capillary tube invasion in an in vivo model of angiogenesis. We show that phenoxodiol inhibits hallmarks of endothelial cell activation, namely TNF or IL-1 induced E-selectin and VCAM-1 expression and IL-8 secretion. However, PXD had no effect on unstimulated endothelial cells. We also describe that PXD inhibits the lipid kinase sphingosine kinase, which recently has been implicated in endothelial cell activation and angiogenesis as well as oncogenesis. Thus, our results suggest that PXD may be an effective anticancer drug targeting the two drivers of tumour growth--the proliferation of the tumour cells themselves and the angiogenic and inflammatory stimulation of the vasculature.
Keywords: flavonoids; cancer; angiogenesis; sphingosine kinase
RMID: 0020060468
DOI: 10.1002/ijc.21682
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.